Scarica l'app Stockscreener
3.35
6.42%
-0.23
Dopo l'orario di chiusura:
3.47
0.12
+3.58%
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
Puma Biotechnology’s (PBYI) Buy Rating Reiterated at HC Wainwright - Defense World
Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance UK
PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates - Yahoo Finance
Puma Biotechnology: Strong Financial Performance and Strategic Developments Justify Buy Rating - TipRanks
GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St
Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Puma Biotechnology Reports Strong Earnings Growth in 2024 - TipRanks
Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects - TipRanks
Puma Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations By Investing.com - Investing.com South Africa
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations - Investing.com
Puma Biotech stock rises as Q4 earnings surpass expectations By Investing.com - Investing.com Canada
Puma Biotech stock rises as Q4 earnings surpass expectations - Investing.com
Puma Biotech: Q4 Earnings Snapshot - The Bakersfield Californian
Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference - BioSpace
Puma Biotechnology Reveals Corporate Strategy at Major Healthcare ConferenceWhat Will CEO Disclose? - StockTitan
Puma Biotechnology Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
Investors in Puma Biotechnology (NASDAQ:PBYI) have unfortunately lost 73% over the last five years - Yahoo Finance
Puma Biotechnology, Inc. to Host Earnings Call - ACCESS Newswire
SG Americas Securities LLC Boosts Stock Position in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Puma Biotech's Crucial Full Year Earnings Reveal: Q4 Financial Results Coming February 27 - StockTitan
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 5, 2025 - BioSpace
Inside Puma Bio's Latest Executive Compensation Move: Key Details on RSU Grants - StockTitan
Millennium Management LLC Reduces Stake in Puma Biotechnology Inc - GuruFocus.com
JPMorgan Chase & Co. Acquires 30,499 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma commences Phase II trial of alisertib for breast cancer treatment - MSN
US Penny Stocks To Watch In January 2025 - Simply Wall St
Zacks Research Analysts Increase Earnings Estimates for PBYI - Defense World
What is Zacks Research's Forecast for PBYI FY2025 Earnings? - MarketBeat
Zacks Research Has Optimistic Outlook of PBYI Q4 Earnings - Defense World
Research Analysts Offer Predictions for PBYI Q4 Earnings - MarketBeat
Barclays PLC Increases Stake in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist? - Yahoo Finance
Jane Street Group LLC Buys 16,374 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Insufficient Growth At Puma Biotechnology, Inc. (NASDAQ:PBYI) Hampers Share Price - Simply Wall St
Zacks Research Has Negative Outlook of PBYI FY2024 Earnings - MarketBeat
Zacks Research Issues Pessimistic Estimate for PBYI Earnings - Defense World
FY2025 EPS Forecast for Puma Biotechnology Raised by Analyst - Defense World
FY2025 EPS Estimate for Puma Biotechnology Lifted by Analyst - MarketBeat
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN
VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates - Yahoo Finance
Geode Capital Management LLC Has $2.34 Million Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Barclays PLC Buys 46,370 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
Best Value Stocks to Buy for January 6th - Yahoo Finance
Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock By Investing.com - Investing.com Australia
Puma Biotechnology's SVP sells $27,208 in stock - Investing.com India
Puma Biotechnology chief commercial officer sells $29,742 in stock By Investing.com - Investing.com Australia
3.13%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):